| Paving the way toward complex blood-brain barrier models using pluripotent stem cells K Lauschke, L Frederiksen, VJ Hall Stem cells and development 26 (12), 857-874, 2017 | 54 | 2017 |
| A novel human pluripotent stem cell-based assay to predict developmental toxicity K Lauschke, AK Rosenmai, I Meiser, JC Neubauer, K Schmidt, ... Archives of Toxicology 94, 3831-3846, 2020 | 31 | 2020 |
| Developmental effects of PFOS, PFOA and GenX in a 3D human induced pluripotent stem cell differentiation model N Davidsen, AK Rosenmai, K Lauschke, T Svingen, AM Vinggaard Chemosphere 279, 130624, 2021 | 23 | 2021 |
| Quantitative in Vitro to in Vivo Extrapolation (QIVIVE) for Predicting Reduced Anogenital Distance Produced by Anti-Androgenic Pesticides in a Rodent Model for … M Scholze, C Taxvig, A Kortenkamp, J Boberg, S Christiansen, T Svingen, ... Environmental health perspectives 128 (11), 117005, 2020 | 21 | 2020 |
| Genetic and functional insights into CDA-I prevalence and pathogenesis AA Olijnik, NBA Roy, C Scott, JA Marsh, J Brown, K Lauschke, K Ask, ... Journal of medical genetics 58 (3), 185-195, 2021 | 11 | 2021 |
| Creating a human-induced pluripotent stem cell-based NKX2. 5 reporter gene assay for developmental toxicity testing K Lauschke, AF Treschow, MA Rasmussen, N Davidsen, B Holst, ... Archives of Toxicology 95, 1659-1670, 2021 | 10 | 2021 |
| Transcriptomic changes upon epoxiconazole exposure in a human stem cell-based model of developmental toxicity K Lauschke, MD Dalgaard, J Emnéus, AM Vinggaard Chemosphere 284, 131225, 2021 | 9 | 2021 |
| A comparative assessment of marker expression between cardiomyocyte differentiation of human induced pluripotent stem cells and the developing pig heart K Lauschke, L Volpini, Y Liu, AM Vinggaard, VJ Hall Stem Cells and Development 30 (7), 374-385, 2021 | 7 | 2021 |
| Omnidirectional leaky opto-electrical fiber for optogenetic control of neurons in cell replacement therapy S Vasudevan, A Dotti, J Kajtez, A Martínez-Serrano, C Gundlach, ... Bioelectrochemistry 149, 108306, 2023 | 1 | 2023 |
| Investigating the applicability domain of the hiPSC-based PluriLum assay: an embryotoxicity assessment of chemicals and drugs AF Treschow, MJ Valente, K Lauschke, B Holst, AR Andersen, ... Archives of Toxicology, 1-16, 2024 | | 2024 |
| PhD Defense K Lauschke Section of Environmental Health, University of Copenhagen, 2021 | | 2021 |
| Using a human induced pluripotent stem cell differentiation model to assess developmental effects of PFOS, PFOA and GenX N Davidsen, AK Rosenmai, K Lauschke, T Svingen Society of Toxicology Annual Meeting and ToxExpo 2021, 2021 | | 2021 |
| Investigating developmental effects of PFAS using a 3D human induced pluripotent stem cell differentiation model AM Vinggaard, N Davidsen, AK Rosenmai, K Lauschke Toxicology Letters 350 (Supplement), S53-S53, 2021 | | 2021 |
| Human induced pluripotent stem cells to study developmental toxicity in vitro. K Lauschke Technical University of Denmark, 2021 | | 2021 |
| An advanced pluripotent stem cell test for developmental toxicity K Lauschke, AK Rosenmai, AF Treschow, J Emnéus, MA Rasmussen, ... 11th World Congress on Alternatives and Animal Use in the Life Sciences: 3Rs …, 2021 | | 2021 |
| Redefining molecular markers of human cardiac differentiation following assessment of early porcine cardiac development L Volpini, K Lauschke, Y Liu, AM Vinggaard, VJ Hall Available at SSRN 3544549, 2020 | | 2020 |
| Quantitative in vitro to in vivo extrapolation (IVIVE) predict adverse male reproductive health disorders caused by pesticides C Taxvig, M Scholze, A Kortenkamp, J Boberg, T Svingen, K Lauschke, ... Toxicology Letters 314 (SI), S38-S38, 2019 | | 2019 |
| Cellekulturer danner blod-hjerne-barrieren i laboratoriet K Lauschke, CVL Schwartz BestPractice Neurologi, 2018 | | 2018 |
